Abstract
Background Malaria poses a significant health challenge in India, with notable contributions to the global malaria burden. This study aims to analyze trends in malaria incidence in India over the past two decades, evaluating the effectiveness of public health interventions.
Objective The objective of this study is to analyze trends in malaria incidence in India over the past decades, evaluate the effectiveness of public health interventions, and project future trends in order to support the country’s goal of malaria elimination by 2030.
Methods A comprehensive 20-year dataset was utilized to conduct time series analyses, including linear regression and ARIMA modeling. The linear regression model assessed the trend in malaria incidence per 1,000 population at risk, while the ARIMA model was used for forecasting future trends. Residuals were evaluated for adequacy to ensure model reliability.
Results The linear regression analysis revealed a significant annual decrease in malaria incidence by approximately 0.92 units (p < 0.001), explaining 90.77% of the variability in the data. The ARIMA model forecasts indicate a continued decline, projecting negative incidence values by 2026 and 2027, despite some residual autocorrelation suggesting further model refinement may be necessary.
Discussion These findings highlight the effectiveness of current public health strategies and the importance of ongoing monitoring to address remaining challenges. The projected downward trend aligns with India’s goal of malaria elimination by 2030, reinforcing the need for sustained interventions in high-burden areas.
Conclusion This study underscores the positive impact of public health initiatives on malaria incidence in India, while emphasizing the necessity for continuous research and adaptive strategies to achieve the ambitious target of malaria eradication by 2030.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding is received.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Supplemental files and abstract updated.
Data Availability
The dataset used in this study are available from World Health Oraganization website.(2)